CTLA-4 Is a Direct Target of Wnt/β-Catenin Signaling and Is Expressed in Human Melanoma Tumors

This publication has 62 references indexed in Scilit:

• The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition
  Journal of Biological Chemistry, 2007
• Cutaneous Malignant Melanoma
  Mayo Clinic Proceedings, 2006
• Low Surface Expression of B7-1 (CD80) Is an Immunoescape Mechanism of Colon Carcinoma
  Cancer Research, 2006
• A Wnt-er Wonderland—The complexity of Wnt signaling in melanoma
  Cancer and Metastasis Reviews, 2005
• THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASE
  Annual Review of Cell and Developmental Biology, 2004
• Genetic and epigenetic alterations of the APC gene in malignant melanoma
  Oncogene, 2004
• Identification of BMP and Activin Membrane-bound Inhibitor (BAMBI), an Inhibitor of Transforming Growth Factor-β Signaling, as a Target of the β-Catenin Pathway in Colorectal Tumor Cells
  Journal of Biological Chemistry, 2004
• CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells
  Blood, 2002
• Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC
  International Journal of Cancer, 2002
• Constitutive Activation of Wnt/β-Catenin Signaling Pathway in Migration-Active Melanoma Cells: Role of LEF-1 in Melanoma with Increased Metastatic Potential
  Biochemical and Biophysical Research Communications, 2001